Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIKAS PROPPANT & GRANITE vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VIKAS PROPPANT & GRANITE TATVA CHINTAN PHARMA VIKAS PROPPANT & GRANITE/
TATVA CHINTAN PHARMA
 
P/E (TTM) x -1.9 77.0 - View Chart
P/BV x 0.2 5.6 2.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 VIKAS PROPPANT & GRANITE   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    VIKAS PROPPANT & GRANITE
Mar-21
TATVA CHINTAN PHARMA
Mar-23
VIKAS PROPPANT & GRANITE/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs62,649 0.2%   
Low Rs21,606 0.1%   
Sales per share (Unadj.) Rs0.5191.1 0.2%  
Earnings per share (Unadj.) Rs-0.220.5 -1.1%  
Cash flow per share (Unadj.) Rs-0.224.8 -0.9%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %00.1 0.0%  
Book value per share (Unadj.) Rs3.6232.2 1.6%  
Shares outstanding (eoy) m514.6822.17 2,321.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.211.1 83.1%   
Avg P/E ratio x-19.2103.7 -18.5%  
P/CF ratio (eoy) x-19.285.7 -22.4%  
Price / Book Value ratio x1.29.2 12.7%  
Dividend payout %09.7 -0.0%   
Avg Mkt Cap Rs m2,18247,157 4.6%   
No. of employees `000NANA-   
Total wages/salary Rs m1386 0.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2364,236 5.6%  
Other income Rs m057 0.0%   
Total revenues Rs m2364,294 5.5%   
Gross profit Rs m-114572 -19.9%  
Depreciation Rs m096 0.0%   
Interest Rs m086 0.0%   
Profit before tax Rs m-114448 -25.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-7 -0.0%   
Profit after tax Rs m-114455 -25.0%  
Gross profit margin %-48.313.5 -357.4%  
Effective tax rate %0-1.6 0.0%   
Net profit margin %-48.310.7 -449.4%  
BALANCE SHEET DATA
Current assets Rs m1,9593,136 62.5%   
Current liabilities Rs m2,0012,361 84.7%   
Net working cap to sales %-17.618.3 -96.4%  
Current ratio x1.01.3 73.7%  
Inventory Days Days763 2,583.7%  
Debtors Days Days26,51973 36,465.3%  
Net fixed assets Rs m1,9304,304 44.8%   
Share capital Rs m515222 232.2%   
"Free" reserves Rs m1,3624,926 27.6%   
Net worth Rs m1,8765,148 36.5%   
Long term debt Rs m042 0.0%   
Total assets Rs m3,8897,439 52.3%  
Interest coverage x06.2-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.10.6 10.7%   
Return on assets %-2.97.3 -40.3%  
Return on equity %-6.18.8 -68.7%  
Return on capital %-6.110.3 -59.0%  
Exports to sales %076.2 0.0%   
Imports to sales %056.9 0.0%   
Exports (fob) Rs mNA3,229 0.0%   
Imports (cif) Rs mNA2,409 0.0%   
Fx inflow Rs m03,229 0.0%   
Fx outflow Rs m02,409 0.0%   
Net fx Rs m0820 0.0%   
CASH FLOW
From Operations Rs m-158278 -56.9%  
From Investments Rs m236-1,011 -23.4%  
From Financial Activity Rs m-78378 -20.7%  
Net Cashflow Rs m0-357 -0.0%  

Share Holding

Indian Promoters % 22.1 72.0 30.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 16.5 -  
FIIs % 0.0 3.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 77.9 28.0 278.6%  
Shareholders   94,295 73,730 127.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VIKAS PROPPANT & GRANITE With:   PIDILITE INDUSTRIES    SRF    BALAJI AMINES    YASHO INDUSTRIES    GHCL    


More on VIKAS PROPPANT & GRANITE vs TATVA CHINTAN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VIKAS PROPPANT & GRANITE vs TATVA CHINTAN PHARMA Share Price Performance

Period VIKAS PROPPANT & GRANITE TATVA CHINTAN PHARMA
1-Day 1.85% -0.86%
1-Month 1.85% 9.95%
1-Year 22.22% -24.23%
3-Year CAGR -38.37% -18.73%
5-Year CAGR -49.18% -11.70%

* Compound Annual Growth Rate

Here are more details on the VIKAS PROPPANT & GRANITE share price and the TATVA CHINTAN PHARMA share price.

Moving on to shareholding structures...

The promoters of VIKAS PROPPANT & GRANITE hold a 22.1% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VIKAS PROPPANT & GRANITE and the shareholding pattern of TATVA CHINTAN PHARMA.

Finally, a word on dividends...

In the most recent financial year, VIKAS PROPPANT & GRANITE paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.

You may visit here to review the dividend history of VIKAS PROPPANT & GRANITE, and the dividend history of TATVA CHINTAN PHARMA.



Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.